alpha-aminopyridine has been researched along with Inflammatory Bowel Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andoh, A; Araki, Y; Bamba, S; Bamba, T; Ban, H; Fujiyama, Y; Hattori, T; Kanauchi, O; Mukaisho, K; Sugihara, H | 1 |
| Deng, J; He, X; He, YM; Huang, Y; Huang, YY; Liu, H; Luo, HB; Wang, Q; Xie, X; Yuan, Y; Zhu, J | 1 |
| Song, SD; Tang, HF | 1 |
| Banner, KH; Trevethick, MA | 1 |
2 review(s) available for alpha-aminopyridine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
[Progress in PDE4 targeted therapy for inflammatory diseases].
Topics: Aminopyridines; Aminoquinolines; Arthritis; Asthma; Benzamides; Cyclopropanes; Dermatitis; Humans; Inflammation; Inflammatory Bowel Diseases; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Sulfones; Thalidomide; Thiazoles | 2014 |
PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Cyclopropanes; Enzyme Inhibitors; Humans; Inflammatory Bowel Diseases; Nitriles | 2004 |
2 other study(ies) available for alpha-aminopyridine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Dextran sulfate sodium administered orally is depolymerized in the stomach and induces cell cycle arrest plus apoptosis in the colon in early mouse colitis.
Topics: Administration, Oral; Aminopyridines; Animals; Apoptosis; Caco-2 Cells; Cell Cycle Checkpoints; Cell Line, Tumor; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C | 2012 |
Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases.
Topics: Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dextran Sulfate; Dipyridamole; Dogs; Inflammatory Bowel Diseases; Mice; Phosphodiesterase 4 Inhibitors | 2022 |